Topic

Ruconest (C1 esterase inhibitor [recombinant])

A collection of 27 issues

Lowering Out-of-Pocket Costs for Ruconest with UnitedHealthcare in North Carolina: Copay Cards, Appeals & Financial Assistance

Answer Box: Getting Ruconest Covered by UnitedHealthcare in North Carolina UnitedHealthcare requires prior authorization for Ruconest (C1 esterase inhibitor [recombinant]) in North Carolina, with 12-month approvals for confirmed hereditary angioedema (HAE) patients prescribed by allergists/immunologists. The fastest path: 1) Have your HAE specialist submit PA via UHC Provider Portal
6 min read

Myths vs. Facts: Getting Ruconest (C1 Esterase Inhibitor) Covered by Blue Cross Blue Shield in Michigan

Answer Box: Getting Ruconest Covered by BCBS Michigan Eligibility: Ruconest requires prior authorization from Blue Cross Blue Shield of Michigan for acute hereditary angioedema (HAE) attacks only—not prophylaxis. Fastest path: Submit PA with confirmed HAE diagnosis (two separate lab tests showing C1-INH deficiency), attack documentation, and specialist prescription. First
6 min read

How to Get Ruconest (C1 Esterase Inhibitor) Covered by Blue Cross Blue Shield in New Jersey: Complete Appeals Guide 2025

Answer Box: Getting Ruconest Covered in New Jersey Blue Cross Blue Shield (BCBS) requires prior authorization for Ruconest (C1 esterase inhibitor, recombinant) in New Jersey. Fastest path to approval: Submit complete documentation including confirmed HAE diagnosis (ICD-10: D84.1), lab evidence (low C4, abnormal C1-INH), and detailed medical necessity letter.
6 min read